Green arrow that points upwards.
Your privacy is our priority.
By clicking ”accept all“, you agree to the storing of cookies on your device to enhance site navigation, analyse site usage, and assist in our marketing efforts. View our privacy policies for more information.
8.11.2023

XO Life among the leading startups in the European digital health market

According to the AlbionVC report, XO Life is one of the leading startups in the European digital health market
The AlbionVC logo is displayed on a wave background

Financing of healthcare technologies in Europe has once again reached historic levels, with artificial intelligence driving a new wave of growth in digital care and digital pharmacy. AlbionVC is now presenting the new report on the European healthtech market, which includes 998 companies from the digital pharmaceutical and digital care sectors. The card focuses on companies that were founded in 2015 or later, have received institutional funding in the last three years and employ more than 10 people. XO Life is one of the leading companies in its sector.

Would you like to find out more or are you interested in XO Life?

Get in touch now, get a demo or answer individual questions in a personal conversation.

XO Life News

Discover even more news

image of impactMonitor for Glenmark
News
Dec 10, 2024

Glenmark launcht eigenen Bereich für Malaria-Prophylaxe und -Therapie auf der ImpactMonitor™-Plattform von XO Life

Glenmark und XO Life bieten Patienten digitalen Support auf der ImpactMonitor™ Plattform an.
Read news
image of impactmonitor for gastritol (dr. gustav klein)
News
Oct 1, 2024

Dr. Gustav Klein and XO Life: Digital therapy support for users of Gastritol® Liquid for gastrointestinal complaints

Gastritol® Liquid now offers digital therapy support via XO Life's ImpactMonitor™ platform.
Read news
image of impactmonitor plattform xo life
News
Aug 21, 2024

XO Life receives 7 Million Euros for the international expansion of its health platform as an alternative to Google, Facebook and Co.

XO Life secures €7 million for global expansion of its ImpactMonitor™ platform, a meta-platform for digital patient support.
Read news
contact form

We connect patients and pharma for a better life

We cannot do this alone. We need you too.
It’s your patients and users who advance our knowledge base.

Request a free demo to find out more.

Message received successfully!
We have successfully received your message. We will get back to you as soon as possible.
Unfortunately that didn't work. Please make sure that you have filled out all details correctly.